IFI-M · USB Tri-Axis Dominant-Primary Series

Specimen SS-F-M3-02499 // MULTI-AXIS · IFI-M

USB Tri-Axis Dominant-Primary Series V-IV

Solanum lycopersicum

Tomato

Tier VUSB Tri-Axis Dominant-Primary Series

Target Trait

2.8×

fold-change

Umami-dominant tri-axis S+B modulated fold-change

Technical Specifications

SKU

SS-F-M3-02499

Genomic Edits

13

GC Content

46.5%

Construct Length

7,006 bp

Promoter System

T7/SP6 cell-free

Expression System

In-vitro cell-free

Host Strain

Cell-free

Receptor Target

mGluR1 + TAS1R2/TAS1R3 + TAS2R38 (suppression)

IFI Score

280

Pathway Edits

  • mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
  • TAS1R2/TAS1R3 pathway primary gene cluster for sweet (IFI-S) tri-axis component
  • TAS2R38 (suppression) pathway primary gene cluster for bitter-attenuation (IFI-B) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent USB pathway operation
  • Cross-pathway regulatory circuit for umami-dominant USB triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: mGluR1, TAS1R2/TAS1R3, and TAS2R38 (suppression) pathways simultaneously engineeredUmami-dominant tri-axis expression strategy (USB) with cross-pathway flux managementCell-free co-translation of multi-axis enzyme sets for in-vitro biochemical validation

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier V USB triple-axis construct for advanced multi-modal sensory architecture combining umami, sweet, and bitter-attenuation axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$9999 · Tier V License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?